![](/img/cover-not-exists.png)
HIGH-DOSE ATORVASTATIN ATTENUATES CARDIOVASCULAR RISK PREDICTION OF THE METABOLIC SYNDROME COMPONENTS: THE TREATING TO NEW TARGETS STUDY
Deedwania, P., Grundy, S., Kastelein, J., Breazna, A.Volume:
9
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(08)70805-5
Date:
May, 2008
File:
PDF, 152 KB
english, 2008